Urinary Bladder Diseases
Information
- Disease name
- Urinary Bladder Diseases
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03245242 | Active, not recruiting | Pediatric Urology Recovery After Surgery Endeavor (PURSUE) | April 1, 2017 | October 31, 2024 | |
| NCT01340027 | Completed | Phase 2 | A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder | March 29, 2011 | June 28, 2012 |
| NCT01638000 | Completed | Phase 3 | A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment. | June 12, 2012 | April 24, 2013 |
| NCT01908829 | Completed | Phase 3 | A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin) | July 10, 2013 | November 25, 2014 |
| NCT01930799 | Completed | Phase 4 | Bladder Management in Patients With Multiple Sclerosis: Optimizing Practice Patterns | August 2013 | March 2015 |
| NCT04914442 | Completed | Eosinophilic Cystitis Mimicking Urothelial Neoplasia | January 17, 2017 | January 20, 2021 | |
| NCT02307487 | Completed | Phase 2 | Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients | December 2014 | June 2017 |
| NCT02320773 | Completed | A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice | November 25, 2014 | July 27, 2016 | |
| NCT02386072 | Completed | A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB) | January 5, 2015 | August 4, 2017 | |
| NCT02891460 | Completed | N/A | Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients | January 2013 | March 2015 |
| NCT03081858 | Completed | Phase 1/Phase 2 | Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer | May 17, 2018 | August 5, 2021 |
| NCT03845725 | Completed | Falls and Balance of Patients With Parkinson's Disease With Urinary Disturbance | February 1, 2018 | June 30, 2019 | |
| NCT04161716 | Completed | N/A | Study Evaluating the Ability of a NIRS Module to Detect a Urodynamic Variation in Humans (DETTECH) | July 7, 2020 | September 30, 2021 |
| NCT05643963 | Not yet recruiting | N/A | The COOKER-BLADDER Trial | April 2023 | December 2024 |
| NCT06237920 | Recruiting | Phase 2 | Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab | February 19, 2024 | August 1, 2028 |
| NCT04442724 | Recruiting | N/A | Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy | July 1, 2020 | August 2024 |
| NCT05153694 | Recruiting | Infectious Complications After Cystectomy: A Prospective Observational Study | December 1, 2021 | November 30, 2024 | |
| NCT05250908 | Recruiting | N/A | INTIBIA Pivotal Study | March 7, 2022 | March 7, 2025 |
| NCT01060254 | Terminated | Phase 2 | A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain | April 6, 2010 | June 24, 2011 |
| NCT00384891 | Terminated | Phase 3 | Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer | February 2002 | December 2013 |
| NCT04922047 | Unknown status | Phase 1/Phase 2 | Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01) | June 2021 | August 2023 |
| NCT02254915 | Withdrawn | Phase 3 | SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D001745